Shengqiang Pan

Title: Innovations of Shengqiang Pan in Pharmaceutical Chemistry

Introduction

Shengqiang Pan is a notable inventor based in Dongguan, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of nitrogen-containing tricyclic compounds. His work focuses on the modulation of FXR, a receptor that plays a crucial role in various metabolic processes.

Latest Patents

Shengqiang Pan holds two patents that highlight his innovative approach to medicine. The first patent describes nitrogen-containing tricyclic compounds and their uses in treating diseases mediated by FXR. This invention includes a variety of forms such as stereoisomers, geometric isomers, and prodrugs. The second patent focuses on novel tricyclic compounds that can bind to FXR, also aimed at treating conditions mediated by this receptor. Both patents emphasize the pharmaceutical compositions containing these compounds and methods for their administration.

Career Highlights

Throughout his career, Shengqiang Pan has worked with prominent companies in the pharmaceutical industry. He has been associated with North & South Brother Pharmacy Investment Company Limited and Sunshine Lake Pharma Co., Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Shengqiang Pan has collaborated with notable professionals in his field, including Xiaojun Wang and Xinye Yang. These collaborations have likely enhanced his research and development efforts, leading to impactful innovations in pharmaceutical chemistry.

Conclusion

Shengqiang Pan's contributions to the field of pharmaceutical chemistry through his patents and collaborations demonstrate his commitment to advancing medical science. His work on tricyclic compounds and their applications in medicine showcases the potential for innovative treatments in the healthcare industry.